Lisata Therapeutics Income Statement (2010-2025) | LSTA

1Y3Y5Y7Y10YAll
Download Data
Income Statement Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Revenue & cost
Revenue (Quarter)
-0.01M-0.00M-0.00M1.00M0.07M0.10M
Gross Profit (Quarter)
Operating items
Research & Development (Quarter)
4.65M2.26M2.12M1.70M1.51M2.04M2.99M3.00M3.18M3.16M3.38M3.01M3.24M2.60M2.54M2.95M2.60M2.25M1.96M1.13M
Selling, General & Administrative (Quarter)
2.67M2.90M2.15M2.06M2.29M2.55M2.36M2.07M3.67M3.71M2.58M3.01M3.36M2.92M2.79M3.00M3.25M2.69M2.46M2.04M
Other Operating Expenses (Quarter)
Operating Expenses (Quarter)
7.32M5.16M4.27M3.76M3.80M4.59M5.35M5.07M6.84M6.88M5.96M6.03M6.60M5.52M5.34M5.95M5.85M4.94M4.41M3.18M
Operating Income (Quarter)
-7.32M-5.16M-4.27M-3.76M-3.80M-4.59M-5.35M-5.07M-6.84M-6.88M-5.96M-6.03M-6.60M-5.52M-5.34M-4.95M-5.85M-4.87M-4.41M-3.08M
EBIT (Quarter)
-7.32M-5.16M-4.27M-3.76M-3.80M-4.59M-5.35M-5.07M-6.84M-6.88M-5.96M-6.03M-6.60M-5.52M-5.34M-4.95M-5.85M-4.87M-4.41M-3.08M
Non-operating items
Interest & Investment Income (Quarter)
0.67M0.67M0.71M0.67M0.59M0.49M0.45M0.35M0.27M0.22M0.18M0.14M
Other Non Operating Income (Quarter)
0.14M0.18M0.19M0.21M0.24M0.23M0.21M0.17M-0.01M-0.15M-0.01M-0.01M-0.19M-0.01M-0.04M-0.01M-0.10M-0.01M-0.02M-0.02M
Non Operating Income (Quarter)
0.13M0.17M0.19M0.21M0.24M0.23M0.21M0.17M0.66M-0.15M0.70M-0.01M-0.19M-0.01M-0.04M-0.01M0.16M-0.01M-0.02M-0.02M
Net income details
EBT (Quarter)
-7.19M-4.98M-4.08M-3.55M-3.56M-4.59M-5.14M-4.90M-6.19M-6.36M-5.26M-5.37M-6.20M-5.04M-4.93M-4.61M-5.69M-4.66M-4.25M-2.95M
Tax Provisions (Quarter)
-3.23M-2.33M-0.80M-0.96M
Profit After Tax (Quarter)
-3.96M-4.98M-4.08M-3.55M-3.56M-4.37M-5.14M-4.90M-6.19M-4.03M-5.26M-5.37M-5.40M-5.04M-4.93M-4.61M-4.72M-4.66M-4.25M-2.95M
Net Income - Minority (Quarter)
Income from Non-Controlling Interests (Quarter)
-0.42M-0.00M-0.00M0.00M0.00M0.00M0.00M0.00M
Income from Continuing Operations (Quarter)
-3.96M-4.98M-4.08M-3.55M-3.56M-4.59M-5.14M-4.90M-6.19M-4.03M-5.26M-5.37M-5.40M-5.04M-4.93M-4.61M-4.72M-4.66M-4.25M-2.95M
Consolidated Net Income (Quarter)
1.07M-4.59M-5.14M-4.90M-6.19M-4.03M-5.26M-5.37M-5.40M-5.04M-4.93M-4.61M-4.72M-4.66M-4.25M-2.95M
Income towards Parent Company (Quarter)
1.07M-4.59M-5.14M-4.90M-6.19M-4.03M-5.26M-5.37M-5.40M-5.04M-4.93M-4.61M-4.72M-4.66M-4.25M-2.95M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)
1.07M-4.98M-4.08M-3.55M-4.37M-5.14M-4.90M-6.19M-4.03M-5.26M-5.37M-5.40M-5.04M-4.93M-4.61M-4.72M-4.66M-4.25M-2.95M
Additional items
EPS (Basic) (Quarter)
-0.38-0.52-0.42-0.36-0.36-0.44-0.49-0.47-0.77-0.50-0.65-0.66-0.65-0.61-0.59-0.55-0.55-0.54-0.49-0.33
EPS (Weighted Average and Diluted) (Quarter)
0.12-0.77-0.50-0.65-0.66-0.65-0.61-0.59-0.55-0.55-0.54-0.49-0.33
Shares Outstanding (Weighted Average) (Quarter)
8.97M9.56M9.58M9.63M9.69M10.03M10.39M10.41M7.99M8.00M8.05M8.07M8.29M8.31M8.31M8.33M8.60M8.61M8.65M8.69M
Shares Outstanding (Diluted Average) (Quarter)
8.97M9.69M7.99M8.02M8.14M8.07M8.29M8.31M8.31M8.33M8.60M8.61M8.65M8.69M
EBITDA (Quarter)
-7.32M-5.16M-4.27M-3.76M-3.80M-4.59M-5.35M-5.07M-6.84M-6.88M-5.96M-6.03M-6.60M-5.52M-5.34M-4.95M-5.85M-4.87M-4.41M-3.08M
Interest Expenses (Quarter)
0.01M0.00M0.00M
Shares Outstanding (Quarter)
0.01M0.01M9.74M0.01M0.01M10.39M10.41M10.41M8.00M8.13M8.14M8.15M8.31M8.32M8.32M8.41M8.62M8.63M8.76M8.83M
Tax Rate (Quarter)
44.8636.6512.8716.92